Prostate-specific Antigen (PSA) Testing Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4170051
- 120 Pages
- February 2021
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Prostate-specific Antigen (PSA) Testing market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Prostate-specific Antigen (PSA) Testing market segmented into
CLIA Method
ELISA Method
Based on the end-use, the global Prostate-specific Antigen (PSA) Testing market classified into
Screening
Post-treatment Monitoring
Others
Based on geography, the global Prostate-specific Antigen (PSA) Testing market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Abbott
Boston Scientific Corporation
Bayer AG
Siemens Healthcare
DiaSorin
Roche
Beckman Coulter
PerkinElmer
Tosoh
Ortho Clinical
Fujirebio
Mediwatch
BodiTech
Bristol-Myers Squibb Company
GE Healthcare
Endocare
Merck＆Co.
Medtronic
Sanofi-Aventis SA
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PROSTATE-SPECIFIC ANTIGEN (PSA) TESTING INDUSTRY
2.1 Summary about Prostate-specific Antigen (PSA) Testing Industry
2.2 Prostate-specific Antigen (PSA) Testing Market Trends
2.2.1 Prostate-specific Antigen (PSA) Testing Production & Consumption Trends
2.2.2 Prostate-specific Antigen (PSA) Testing Demand Structure Trends
2.3 Prostate-specific Antigen (PSA) Testing Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 CLIA Method
4.2.2 ELISA Method
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Screening
4.3.2 Post-treatment Monitoring
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 CLIA Method
5.2.2 ELISA Method
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Screening
5.3.2 Post-treatment Monitoring
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 CLIA Method
6.2.2 ELISA Method
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Screening
6.3.2 Post-treatment Monitoring
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 CLIA Method
7.2.2 ELISA Method
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Screening
7.3.2 Post-treatment Monitoring
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 CLIA Method
8.2.2 ELISA Method
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Screening
8.3.2 Post-treatment Monitoring
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 CLIA Method
9.2.2 ELISA Method
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Screening
9.3.2 Post-treatment Monitoring
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Abbott
10.1.2 Boston Scientific Corporation
10.1.3 Bayer AG
10.1.4 Siemens Healthcare
10.1.5 DiaSorin
10.1.6 Roche
10.1.7 Beckman Coulter
10.1.8 PerkinElmer
10.1.9 Tosoh
10.1.10 Ortho Clinical
10.1.11 Fujirebio
10.1.12 Mediwatch
10.1.13 BodiTech
10.1.14 Bristol-Myers Squibb Company
10.1.15 GE Healthcare
10.1.16 Endocare
10.1.17 Merck＆Co.
10.1.18 Medtronic
10.1.19 Sanofi-Aventis SA
10.2 Prostate-specific Antigen (PSA) Testing Sales Date of Major Players (2017-2020e)
10.2.1 Abbott
10.2.2 Boston Scientific Corporation
10.2.3 Bayer AG
10.2.4 Siemens Healthcare
10.2.5 DiaSorin
10.2.6 Roche
10.2.7 Beckman Coulter
10.2.8 PerkinElmer
10.2.9 Tosoh
10.2.10 Ortho Clinical
10.2.11 Fujirebio
10.2.12 Mediwatch
10.2.13 BodiTech
10.2.14 Bristol-Myers Squibb Company
10.2.15 GE Healthcare
10.2.16 Endocare
10.2.17 Merck＆Co.
10.2.18 Medtronic
10.2.19 Sanofi-Aventis SA
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Prostate-specific Antigen (PSA) Testing Product Type Overview
2.Table Prostate-specific Antigen (PSA) Testing Product Type Market Share List
3.Table Prostate-specific Antigen (PSA) Testing Product Type of Major Players
4.Table Brief Introduction of Abbott
5.Table Brief Introduction of Boston Scientific Corporation
6.Table Brief Introduction of Bayer AG
7.Table Brief Introduction of Siemens Healthcare
8.Table Brief Introduction of DiaSorin
9.Table Brief Introduction of Roche
10.Table Brief Introduction of Beckman Coulter
11.Table Brief Introduction of PerkinElmer
12.Table Brief Introduction of Tosoh
13.Table Brief Introduction of Ortho Clinical
14.Table Brief Introduction of Fujirebio
15.Table Brief Introduction of Mediwatch
16.Table Brief Introduction of BodiTech
17.Table Brief Introduction of Bristol-Myers Squibb Company
18.Table Brief Introduction of GE Healthcare
19.Table Brief Introduction of Endocare
20.Table Brief Introduction of Merck＆Co.
21.Table Brief Introduction of Medtronic
22.Table Brief Introduction of Sanofi-Aventis SA
23.Table Products & Services of Abbott
24.Table Products & Services of Boston Scientific Corporation
25.Table Products & Services of Bayer AG
26.Table Products & Services of Siemens Healthcare
27.Table Products & Services of DiaSorin
28.Table Products & Services of Roche
29.Table Products & Services of Beckman Coulter
30.Table Products & Services of PerkinElmer
31.Table Products & Services of Tosoh
32.Table Products & Services of Ortho Clinical
33.Table Products & Services of Fujirebio
34.Table Products & Services of Mediwatch
35.Table Products & Services of BodiTech
36.Table Products & Services of Bristol-Myers Squibb Company
37.Table Products & Services of GE Healthcare
38.Table Products & Services of Endocare
39.Table Products & Services of Merck＆Co.
40.Table Products & Services of Medtronic
41.Table Products & Services of Sanofi-Aventis SA
42.Table Market Distribution of Major Players
43.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
44.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
45.Table Global Prostate-specific Antigen (PSA) Testing Market Forecast (Million USD) by Region 2021f-2026f
46.Table Global Prostate-specific Antigen (PSA) Testing Market Forecast (Million USD) Share by Region 2021f-2026f
47.Table Global Prostate-specific Antigen (PSA) Testing Market Forecast (Million USD) by Demand 2021f-2026f
48.Table Global Prostate-specific Antigen (PSA) Testing Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
